1. Bernardo, B.C., Weeks, K.L., Pretorius, L., and McMullen, J.R., Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies, Pharmacol. Ther., 2010, vol. 128, no. 1, p. 191.
2. Cohn, J.N., Bristow, M.R., Chien, K.R., et al., Report of the national heart, lung, and blood institute special emphasis panel on heart failure research, Circulation, 1997, vol. 95, no. 4, p. 766.
3. Britsch, S., The Neuregulin-I/ErbB Signaling System in Development and Disease, Adv. Anat. Embryol. Cell Biol. Ser., vol. 190, Berlin: Springer-Verlag, 2007, p. 1.
4. Meyer, D., Yamaai, T., Garratt, A., et al., Isoform-specific expression and function of neuregulin, Development, 1997, vol. 124, no. 18, p. 3575.
5. Lemmens, K., Doggen, K., and Keulenaer, G., Neuregulin-1 and its potential role in the control of cardiac function, Heart Failure Monit., 2008, vol. 5, no. 4, p. 119.